The eyonis™ Lung Cancer Screening (LCS) REALITY data – What leading U.S. clinical pulmonology experts are saying

November 7, 2024

We invite you to join this KOL webinar featuring two globally recognized U.S. pulmonology experts to get their views on the data from REALITY and how eyonis™ LCS may impact lung cancer diagnostics and treatment practices in the real world. Panelists include Prof. Anil Vachani, from the Hospital of the University of Pennsylvania, and Prof. Javier Zulueta, from the Icahn School of Medicine at Mt Sinai. Fredrik Brag, CEO of Median Technologies, also will participate and summarize the final REALITY results, which are going to be submitted in H1 2025 to regulators for U.S. and EU marketing authorizations for eyonis™ LCS.

Register To Our Live Webcast

Get to Know Median’s iSee® Portal

When it comes to being well-informed about your oncology clinical trial imaging workflows, Median’s iSee® Portal is the right foundation for you to be more data driven, agile and strategic.

Purpose-built from the ground up, our configurable solution is intuitive, easy-to-use and mines the clinical trial study image workflow to provide detailed visualizations and robust reporting. iSee® Portal helps minimize trial costs, reduce delays, and increase accuracy – all while boosting efficiency and reducing reader variability.

Simplify and optimize the clinical trial imaging workflow with intelligent visualizations and operational reporting

Site Management

Image Collection

Data and Queries Management

Reads Management

With Median iSee® Portal you can:

  • Identify risks or issues for immediate preventive or corrective actions
  • Easily monitor imaging operational data and quality metrics in real-time
  • Limit reader subjectivity
  • Reduce inter-reader variability
  • Increase accuracy and reproducibility
  • Manage both routine and advanced imaging biomarkers

Gain Efficiencies and Boost Operation Performance

Maximize value and reduce risks with the right clinical trial imaging reporting tool. Put Median’s iSee® Portal to work for you today.

Explore more

Median iCRO

As a global market leader in oncology clinical trial imaging, Median iCRO helps life science companies transform imaging data into life-changing insights.

Our innovative tools and techniques, and scientific and domain expertise have set a new standard in leveraging clinical trial imaging insights, improving the probability of oncology R&D success.

Learn More

Median Imaging Lab

Get more value from your clinical trials with our new transformative solution, Median Imaging Lab.

Using AI, ML, data mining and radiomics you can extract much more from clinical trial images than the industry has ever seen before. Our insightful image data enables you to select the most appropriate patients, predict response to therapy, and accurately monitor disease progression and efficacy of treatments.

Learn More

iSee® Viewer

Gain expert oversight of clinical trial images with our proprietary, flexible software that helps identify, quantify, and track lesions across all time points.

Reduce human error and cover a wide range of solid tumors across cancer indications.

Learn More

Explore what we can do for you to help improve the lives of cancer patients and their families.

Median iCRO

intelligent. insightful. innovative.

Where valuable clinical trial imaging data and analytics intersect with advancing human health.

CONTACT US
Request a proposal
Request a demo